Evidence map›Paper›PMID 33108567›Full record

ArticleClinical journal of gastroenterology2021

Pneumothorax during lenvatinib treatment for hepatocellular carcinoma with lung metastasis.

Yasuhiro Kawanishi, Michio Kuwahara, Masato Utsunomiya, Nobuko Ishida, Yoichi Ishikawa, Makoto Hiroi, Toyokazu Akimori

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Clinical journal of gastroenterology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Yasuhiro KawanishiDepartment of Surgery, Kochi Prefectural Hata Kenmin Hospital, 3-1Yoshina, Yamanachou, Sukumo, 788-0785, Japan. ykawanishi0510@gmail.com.ORCID http://orcid.org/0000-0003-2330-7323
Michio KuwaharaDepartment of Surgery, Kochi Prefectural Hata Kenmin Hospital, 3-1Yoshina, Yamanachou, Sukumo, 788-0785, Japan.
Masato UtsunomiyaDepartment of Surgery, Kochi Prefectural Hata Kenmin Hospital, 3-1Yoshina, Yamanachou, Sukumo, 788-0785, Japan.
Nobuko IshidaDepartment of Surgery, Kochi Prefectural Hata Kenmin Hospital, 3-1Yoshina, Yamanachou, Sukumo, 788-0785, Japan.
Yoichi IshikawaDepartment of Surgery, Kochi Prefectural Hata Kenmin Hospital, 3-1Yoshina, Yamanachou, Sukumo, 788-0785, Japan.
Makoto HiroiDepartment of Surgery, Kochi Prefectural Hata Kenmin Hospital, 3-1Yoshina, Yamanachou, Sukumo, 788-0785, Japan.
Toyokazu AkimoriDepartment of Surgery, Kochi Prefectural Hata Kenmin Hospital, 3-1Yoshina, Yamanachou, Sukumo, 788-0785, Japan.
Makino Botanical Garden · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lenvatinib is an inhibitor of tyrosine kinases, such as vascular endothelial growth factor receptor and fibroblast growth factor receptor, and was first approved for use in thyroid cancer in 2015 in Japan. Additional approval was given in March 2018 for its use as a first-line treatment for advanced or unresectable hepatocellular carcinoma. Herein, we report a case of pneumothorax during lenvatinib treatment for multiple lung metastases of hepatocellular carcinoma in a 71-year-old man. Although the development of pneumothorax during treatment with anticancer agents for lung metastases is well-known, this is the first report of pneumothorax induced by lenvatinib during treatment for lung metastases of hepatocellular carcinoma.

Indexed as

Antineoplastic AgentsCarcinoma, HepatocellularLiver NeoplasmsLung NeoplasmsPneumothoraxAgedHumansJapanMalePhenylurea CompoundsProtein Kinase InhibitorsQuinolinesVascular Endothelial Growth Factor AAntineoplastic AgentslenvatinibPhenylurea CompoundsProtein Kinase InhibitorsQuinolinesVascular Endothelial Growth Factor AHepatocellular carcinomaLenvatinibLung metastasisPneumothorax

Identifiers

PMID33108567
OpenAlexW3097237383

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.